Cambridge, MA · Founded 2016 · Privately Held (backing)
Developer of digital therapeutics designed to treat neurodegenerative disorders by modulating brain activity and targeting underlying disease mechanisms associated with cognitive decline. Cognito Therapeutics is based in Cambridge, MA and was founded in 2016. Its last reported valuation was $30 million in Jul 2016. It has raised $264 million across 2 recorded rounds; the latest was a $10.2 million early-stage round in Jun 2024.
Last reported valuation
$30.0M
Oct 2026
Priced at
—
Total raised
$264.4M
Last round
Early Stage VC
Jun 2024
Cap table — not yet on record
Cognito Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cognito Therapeutics with a free account
·The complete investor list: 11 names
·Watch Cognito Therapeutics: the Monday email on marks, rounds and moves
Where does Cognito Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cognito Therapeutics's 2 recorded funding rounds.
